Electrochemotherapy in cancer treatment

Advances in Clinical and Experimental Medicine

Volumn 16, Issue 5, 2007, Pages 601-607

  Kotulska, Małgorzata ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Cancer; Drug internalization; Electrochemotherapy; Electroporation

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYTOTOXIC AGENT; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 2; PACLITAXEL; TIRAPAZAMINE;

ANTINEOPLASTIC ACTIVITY; BOLUS INJECTION; CANCER CHEMOTHERAPY; CIRCULATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CYTOTOXICITY; DRUG RESPONSE; DRUG TRANSPORT; EDITORIAL; ELECTRIC FIELD; ELECTROCHEMOTHERAPY; ELECTROPORATION; ERYTHEMA; GENETIC TRANSFECTION; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; HYPERKERATOSIS; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROSIS; METASTASIS; MYALGIA; NEOPLASM; NONHODGKIN LYMPHOMA; NONHUMAN; SKIN ABRASION; SKIN INDURATION; TESTIS CARCINOMA; UNSPECIFIED SIDE EFFECT;

EID: 37349066506     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (40)

1. Beebe SJ, Fox PM, Rec LJ, Lauren E, Willis K, Schoenbach H: Nanosecond, high intensity pulsed electric fields induce apoptosis in human cells. FASEB 2003, 17, 1493-1495.
2. Byrne CM, Thompson JF: Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Rev Anticancer Ther 2006, 6, 671-678.
3. Cemazar M, Parkins CS, Holder AL, Kranjc S, Chaplin Dj, Sersa G: Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice. Anticancer Res 2001, 21, 1151-1156.
4. Chang DC, Chassy BM, Saunders JA, Sowers AE (Eds.): Guide to Electroporation and Electrofusion. Academic Press, San Diego 1992.
5. Dev SB, Rabussay DP, Widera G, Hofmann GA: Medical applications of electroporation. IEEE Transactions on Plasma Sci 2000, 28, 206-223.
6. Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, Mir LM: In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999, 1428, 233-240.
7. Gehl J, Skovsgaard T, Mir LM: Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 1998, 9, 319-325.
8. Gilbert RA, Jaroszeski MJ, Heller R: Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997, 1334, 9-14.
9. Gothelf A, Mir LM, Gehl J: Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003, 29, 371-387.
10. Heller R, Gilbert R, Jaroszeski MJ: Clinical applications of electrochemothrapy. Adv Drug Deliv Rev 1999, 35, 119-129.
11. Heller LC, Heller R: In vivo electroporation for gene therapy. Hum Gene Ther 2006, 17, 890-897.
12. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R: Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000, 11, 201-208.
13. Kalinowski S: Elektrochemia membran lipidowych. Wyd. Uniwersytetu Warmińsko-Mazurskiego 2004.
14. Kalinowski S, Koronkiewicz S, Kotulska M, Kubica K: Simulation of electroporated cell by chronopotentiometry. Bioelectrochemistry 2007, 70, 83-90.
15. Koronkiewicz S, Kalinowski S, Bryl K: Programmable chronopotentiometry as a tool for the study of electroporation and resealing of pores in bilayer lipid membranes. Biochim Biophys Acta 2002, 1561, 222-229.
16. Kotulska M, Koronkiewiez S, Kalinowski S: Cholesterol induced changes in the characteristics of the time series from planar lipid bilayer membrane during electroporation. Acta Phys Pol B 2002, 33, 1115-1124.
17. Kotulska M, Koronkiewicz S, Kalinowski S: Self-similar processes and flicker noise from a fluctuating nanopore in a lipid membrane. Phys Rev E 2004, 69, 031920-031930.
18. Kotulska M: 1/f noise in nanopores and its potential application in biosensors. Elektronika 2004, 8-9, 130-134.
19. Kotulska M, Kubica K: Structural and energetical effects of ionic strength in modeling lipid membranes. Acta Phys Pol B 2005, 36, 1641-1651.
20. Kotulska M, Kubica K: Structural and energetic model of the mechanisms for reduced self-diffusion in a lipid bilayer with increasing ionic strength. Phys Rev E 2005, 72, 061903-061909.
21. Kotulska M, Kubica K, Koronkiewicz S, Kalinowski S: Modeling the induction of lipid membrane electropermeabilization. Bioelectrochemistry 2007, 70, 64-70.
22. Kotulska M: Natural fluctuations of an electropore show fractional Lévy stable motion. Biophys J 2007, 92, 2412-2421.
23. Kranjc S, Cemazar M, Grosel A, Sentjurc M, Sersa G: Radiosensitising effect of electrochernotherapy with bleomycin in LPB sarcoma cells and tumors in mice. BMC Cancer 2005, 5, 115-124.
24. Labanauskiene J, Gehl J, Didziapetriene J: Evaluation of cytotoxic effect of photodynamic therapy in combination with electroporation in vitro. Bioelectrochemistry 2007, 70, 78-82.
25. Maxim PG, Carson JJ, Ning S, Knox SJ, Boyer AL, Hsu CP, Benaron DA, Walleczek J: Enhanced effectiveness of radiochemotherapy with tirapazamine by local application of electric pulses to tumors. Radiat Res 2004, 162, 185-193.
26. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr: Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992, 3, 331-334.
27. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr, Kourilsky P: Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol 1995, 17, 30-38.
28. Mir LM, Orlowski S: Mechanisms of electrochemotherapy. Adv Drug Deliv Rev 1999, 35, 107-118.
29. Mir LM, Ed.: Eur J Cancer - Supplements 2006, 4, 1-51.
30. Neumann E, Kakorin S, Toensing K: Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 1999, 48, 3-16.
31. Okino M, Mohri H: Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res 1987, 78, 1319-1321.
32. Orlowski S, Belehradek J Jr, Paoletti C, Mir LM: Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988, 37, 4727-4733.
33. Orlowski S, An D, Belehradek J Jr, Mir LM: Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor. Anticancer Drugs 1998, 9, 551-556.
34. Pucihar G, Mir LM, Miklavcic D: The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry 2002, 57, 167-172.
35. Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, Bognel C, Belehradek J Jr, Munck JN, Mir LM: Electrochemotherapy on liver tumours in rabbits. Br J Cancer 1998, 77, 2104-2111.
36. Schantz SP, Hsu TC, Ainslie N, Moser RP: Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA 1989, 262, 3313-3315.
37. Sersa G, Cemazar M, Miklavcic D: Antitumor effectiveness of electrochemotherapy with cis-diammine-dichloroplatinum(II) in mice. Cancer Res 1995, 55, 3450-3455.
38. Snoj M, Rudolf Z, Cemazar M, Jancar B, Sersa G: Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs 2005, 16, 345-348.
39. Weaver JC, Chizmadzhev YA: Theory of electroporation: a review. Bioelectrochem Bioenerg 1996, 41, 135-160.
40. Whelan MC, Larkin JO, Collins CG, Cashman J, Breathnach O, Soden DM, O'Sullivan GC: Effective treatment of an extensive recurrent breast cancer which was refractory to multimodal therapy by multiple applications of electrochemotherapy. Eur J Cancer Supplements 2006, 4, 32-34.